S
Suzanne Oparil
Researcher at University of Alabama at Birmingham
Publications - 941
Citations - 122414
Suzanne Oparil is an academic researcher from University of Alabama at Birmingham. The author has contributed to research in topics: Blood pressure & Angiotensin II. The author has an hindex of 106, co-authored 885 publications receiving 113983 citations. Previous affiliations of Suzanne Oparil include Michigan State University & Oregon Health & Science University.
Papers
More filters
Journal ArticleDOI
Rapid Communication: Exaggerated Depressor Response to 6-lodoamiloride in NaCl-Sensitive Spontaneously Hypertensive Rats
TL;DR: In this article, the effect of 6-iodoamiloride and analog of the sodium channel blocker amilorides on mean arterial pressure (MAP) was examined in conscious, freely moving NaCl-sensitive spontaneously hypertensive rats (SHR-S) fed high (8%) or normal (1%) NaCl diets.
Journal ArticleDOI
Guidelines for managing high blood pressure--reply.
TL;DR: This is a data-driven study that aims to clarify the role of emotion in the development of Alzheimer's disease and aims to provide a simple, scalable, and scalable approach to diagnose and treat these diseases.
Journal ArticleDOI
The use of complementary peptides in the purification of an angiotensin II binding protein.
TL;DR: This is the first report of purification of an Ang II receptor binding protein which retains its capacity to specifically bind 125I-Ang II.
Journal ArticleDOI
Hormone Therapy of Premature Ovarian Failure : The Case for Natural Estrogen
TL;DR: Ovarian hormones play an important role in women’s health, providing the most reliable and convenient means of contraception and of relieving menopausal symptoms, and hormone therapy of women with ovarian failure continues to be a topic of active debate in the scientific and popular literature.
Journal ArticleDOI
Induced pluripotent stem cell-derived endothelial cells attenuate lipopolysaccharide-induced acute lung injury
Dongqi Xing,J. Michael Wells,J. Michael Wells,Samantha Giordano,Wenguang Feng,Amit Gaggar,Amit Gaggar,Jie Yan,Fadi G. Hage,Fadi G. Hage,Li Li,Li Li,Yiu-Fai Chen,Suzanne Oparil +13 more
TL;DR: These provocative findings provide strong evidence that targeted delivery of iPS-ECs overexpressing CXCR1/2 or CCR2/5 prevents LPS-induced acute lung injury.